168 related articles for article (PubMed ID: 22029194)
1. The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction.
Ghanavatian S; Stein RA; Atar D; Hole L; Agewall S
Clin Lab; 2011; 57(9-10):771-6. PubMed ID: 22029194
[TBL] [Abstract][Full Text] [Related]
2. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
4. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
5. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
6. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
[TBL] [Abstract][Full Text] [Related]
8. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
9. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
[TBL] [Abstract][Full Text] [Related]
10. [Serum B-type natriuretic peptide changes in patients with acute myocardial infarction].
Mao Y; Yang YJ; Zhang J; Zhao XY; Ni XH; Chen JL; Gao RL; Chen ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):425-8. PubMed ID: 16776957
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation.
Bassan R; Potsch A; Maisel A; Tura B; Villacorta H; Nogueira MV; Campos A; Gamarski R; Masetto AC; Moutinho MA
Eur Heart J; 2005 Feb; 26(3):234-40. PubMed ID: 15618053
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study.
Menown IB; Mathew TP; Gracey HM; Nesbitt GS; Murray P; Young IS; Adgey AA;
Am Heart J; 2003 Jun; 145(6):986-92. PubMed ID: 12796753
[TBL] [Abstract][Full Text] [Related]
16. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Adv Ther; 2009 May; 26(5):531-4. PubMed ID: 19475367
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of patients with acute chest pain of uncertain origin by means of serial measurement of high-sensitivity C-reactive protein].
Lozano T; Ena J; Almenar V; Graells M; Molina J; Antorrena I; de la Guía F
Rev Esp Cardiol; 2007 Aug; 60(8):817-24. PubMed ID: 17688850
[TBL] [Abstract][Full Text] [Related]
18. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML
Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356
[TBL] [Abstract][Full Text] [Related]
20. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]